CN118541163A - 用于治疗皮肤病的微生物组合物 - Google Patents

用于治疗皮肤病的微生物组合物 Download PDF

Info

Publication number
CN118541163A
CN118541163A CN202280088350.0A CN202280088350A CN118541163A CN 118541163 A CN118541163 A CN 118541163A CN 202280088350 A CN202280088350 A CN 202280088350A CN 118541163 A CN118541163 A CN 118541163A
Authority
CN
China
Prior art keywords
composition
strain
seq
sequence
bacterial strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280088350.0A
Other languages
English (en)
Chinese (zh)
Inventor
杰瑞德·克厄
贝尔纳多·塞万提斯
谢利·阿克曼
阿卜杜勒拉赫曼·哈萨巴拉
基顿·阿门特劳特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Conseto Biosciences Inc
Original Assignee
Conseto Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conseto Biosciences Inc filed Critical Conseto Biosciences Inc
Publication of CN118541163A publication Critical patent/CN118541163A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN202280088350.0A 2021-11-11 2022-11-10 用于治疗皮肤病的微生物组合物 Pending CN118541163A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163278134P 2021-11-11 2021-11-11
US63/278,134 2021-11-11
PCT/US2022/079637 WO2023086883A1 (en) 2021-11-11 2022-11-10 Microbial compositions for the treatment of skin diseases

Publications (1)

Publication Number Publication Date
CN118541163A true CN118541163A (zh) 2024-08-23

Family

ID=86336611

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280088350.0A Pending CN118541163A (zh) 2021-11-11 2022-11-10 用于治疗皮肤病的微生物组合物

Country Status (8)

Country Link
US (3) US12115197B2 (https=)
EP (1) EP4429683A1 (https=)
JP (1) JP2024544960A (https=)
KR (1) KR20240117164A (https=)
CN (1) CN118541163A (https=)
AU (1) AU2022388745A1 (https=)
CA (1) CA3237750A1 (https=)
WO (1) WO2023086883A1 (https=)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2660645C (en) 2006-08-11 2016-04-05 Novozymes Biologicals, Inc. Bacillus cultures for use in washing, cleaning, stain removal, or degrading waste materials
KR100878799B1 (ko) * 2007-03-13 2009-01-14 한국생명공학연구원 항생제 내성 병원성 미생물 또는 장내 유해 미생물의생장을 억제하는 바실러스 아밀로리퀴페시언스 ｋ317
JP2016509003A (ja) * 2013-02-04 2016-03-24 セレス セラピューティクス インコーポレイテッド 組成物および方法
US20160073642A1 (en) 2013-05-03 2016-03-17 Universidad Eafit Production process for biomass and fengycin metabolites of bacillus species and compositions thereof for biological pest control
US20180289751A1 (en) * 2015-05-05 2018-10-11 The Regents Of The University Of California Antimicrobial therapy
WO2018049182A2 (en) 2016-09-08 2018-03-15 Locus Solutions, Llc Distributed systems for the efficient production and use of microbe-based compositions
KR20190140063A (ko) 2017-05-07 2019-12-18 로커스 아이피 컴퍼니 엘엘씨 피부 건강을 위한 화장품 조성물 및 이를 사용하는 방법
EP3784807B1 (en) 2018-04-23 2025-06-04 Evonik Operations GmbH Synbiotic compositions
US20220096574A1 (en) 2019-01-29 2022-03-31 Holobiome, Inc. Methods and compositions for treating and preventing central nervous system disorders and other conditions caused by gut microbial dysbiosis
JP7689077B2 (ja) 2019-02-11 2025-06-05 エボニック オペレーションズ ゲーエムベーハー バシラエン産生細菌またはその調製物を含有する組成物
MX2021012558A (es) * 2019-04-17 2022-01-04 Andes Ag Inc Metodos innovadores para el tratamiento de las semillas y componentes para mejorar los atributos y el rendimiento de la planta.
BR112021023020A2 (pt) 2019-05-20 2022-01-04 Evonik Operations Gmbh Uso de ésteres de poliglicerol como carreador para ingredientes microbiológicos ativos
MX2021015725A (es) 2019-06-19 2022-04-01 Basf Corp Formulaciones agroquimicas acuosas que comprenden esporas de bacterias.
GB201911925D0 (en) 2019-08-20 2019-10-02 Sporegen Ltd Formulations for prevention or reduction of c. difficile infections
CA3187427A1 (en) 2020-06-17 2021-12-23 Bioconsortia, Inc. Agriculturally beneficial microbes, microbial compositions, and consortia
EP4223301A1 (en) 2020-09-07 2023-08-09 Il Dong Pharmaceutical Co., Ltd. Composition for preventing or treating periodontal diseases, comprising bacillus velezensis strain, culture medium thereof, or culture supernatant thereof as active ingredient
JP2023543355A (ja) 2020-09-25 2023-10-13 バイオームエディット・エルエルシー プロバイオティックバチルス属組成物及び使用方法
WO2022119895A1 (en) 2020-12-01 2022-06-09 Dupont Us Holding, Llc Methods and compositions for microbial treatment of skin disorders
IL305939A (en) 2021-03-14 2023-11-01 The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo Bacillus antibacterial agents
WO2022226376A2 (en) 2021-04-22 2022-10-27 Indigo Ag, Inc. Endophyte compositions and methods for improved plant health
WO2023091342A1 (en) 2021-11-16 2023-05-25 Phibro Animal Health Corporation Preservation system for stabilizing spore-forming microbials

Also Published As

Publication number Publication date
US12329787B2 (en) 2025-06-17
WO2023086883A1 (en) 2023-05-19
US20240424033A1 (en) 2024-12-26
AU2022388745A1 (en) 2024-05-30
JP2024544960A (ja) 2024-12-05
US12115197B2 (en) 2024-10-15
CA3237750A1 (en) 2023-05-19
US20250268955A1 (en) 2025-08-28
US20240189369A1 (en) 2024-06-13
KR20240117164A (ko) 2024-07-31
EP4429683A1 (en) 2024-09-18

Similar Documents

Publication Publication Date Title
EP3471836B1 (en) Dermatological preparations for maintaining and/or restoring healthy skin microbiota
JP2019513769A (ja) アトピー性皮膚炎を処置するためのグラム陰性種の使用
EP3910053A1 (en) Composition for strengthening skin barrier, moisturizing skin or anti-aging
JP2021527134A (ja) 皮膚状態の処置のための組成物
CN118541163A (zh) 用于治疗皮肤病的微生物组合物
TW202220681A (zh) 皮膚細菌叢改善劑及皮膚細菌叢改善用皮膚外用劑
KR102855517B1 (ko) 스타필로코커스 코흐니 균주 및 그의 피부 상태 개선 용도
WO2024027786A1 (zh) 痤疮丙酸杆菌、其应用、组合物和药物
US11752091B2 (en) Composition for strengthening skin barrier, moisturizing skin or anti-aging
CN110769840A (zh) 源自节螺藻属的提取物及其用途
KR102609658B1 (ko) 쿠프리아비더스 메탈리듀란스 균주 및 그의 피부 항당화, 피부 상태 개선 용도
KR102855524B1 (ko) 스트렙토코커스 파라상귀니스 균주 및 그의 피부 상태 개선 용도
KR102855510B1 (ko) 스트렙토코커스 오우스트랄리스 균주 및 그의 피부 상태 개선 용도
KR102855522B1 (ko) 스트렙토코커스 오랄리스 균주 및 그의 피부 상태 개선 용도
KR102855505B1 (ko) 스트렙토코커스 파이오제네스 균주 및 그의 피부 상태 개선 용도
KR102855523B1 (ko) 스트렙토코커스 도우니 균주 및 그의 피부 상태 개선 용도
KR102855509B1 (ko) 스트렙토코커스 룹네리 균주 및 그의 피부 상태 개선 용도
KR102855511B1 (ko) 스트렙토코커스 루테티엔시스 균주 및 그의 피부 상태 개선 용도
KR102855514B1 (ko) 스트렙토코커스 엔지노서스 균주 및 그의 피부 상태 개선 용도
KR102855513B1 (ko) 스트렙토코커스 슈도뉴모니에 균주 및 그의 피부 상태 개선 용도
KR102855530B1 (ko) 스트렙토코커스 할리코에리 균주 및 그의 피부 상태 개선 용도
KR102855512B1 (ko) 스트렙토코커스 뮤탄스 균주 및 그의 피부 상태 개선 용도
KR102544440B1 (ko) 피부 상재균으로부터 유래된 엔테로박터 에어로게네스 j2k-739 균주 및 피부 상재균 유래 엔테로박터속을 자극원으로 처리하는 신규한 항주름평가 방법
KR102855520B1 (ko) 스타필로코커스 캐피티스 아종 유레알리티쿠스 균주 및 그의 피부 상태 개선 용도
KR102855529B1 (ko) 스트렙토코커스 마실리엔시스 균주 및 그의 피부 상태 개선 용도

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination